Skip to Main Content

Paper Details

Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity.
JAMA Ophthalmol
6
2021
Author NameAffiliation
Michele MeliaJaeb Center for Health Research
  • 1 - 1

Datasets

Release 1.2